FREDRICK MAKUMBI
ID:
|
Performance Monitoring for Action (PMA) Uganda
REFNo: HS625ES
General objective
To monitor change in contraceptive availability and use in Uganda and increase understanding of the factors contributing to that change through panel surveys in order to support FP program monitoring and improve performance.
Specific objectives
Specifically, the project aims to conduct cross-sectional and panel surveys at the female, household, and service delivery levels, with a focus on actionable programmatic data on contraceptive availability and use dynamics in targeted geographic areas in order:
1. To measure and monitor key family planning indicators of programmatic relevance cross-sectionally on an annual basis including contraceptive prevalence rate and stocks of contraceptive commodities in Service Delivery Points serving the Enumeration Areas
2. To assess the determinants and consequences of contraceptive availability and use dynamics in Uganda.
3. To evaluate factors associated with a change in contraceptive use states including: Contraceptive acceptor (non-user to user), Contraceptive discontinuer (user to non-user), and Contraceptive switcher (user of one method to a different method)
|
Uganda |
2020-06-04 |
2023-06-04 |
Medical and Health Sciences |
|
Non-degree Award |
|
ANNET NAGUUDI
ID: UNCST-2022-R009395
|
CLIENT EXIT INTERVIEWS (CEIs) UNDER THE WOMEN INTEGRATED SEXUAL HEALTH (WISH) PROGRAMME IN UGANDA
REFNo: HS591ES
The specific objectives are to:
1. Characterize users of family planning (FP) services
2. Estimate the percentage of users of FP services by WISH (Women Integrated Sexual Health) service delivery points who are under-age 20
3. Estimate the percentage of clients of FP services provided by WISH service delivery points who are living in poverty
4. Provide information needed to estimate the number of additional users of modern methods of contraception contributed by WISH
5. Estimate the percentage of WISH FP clients counselled on a range of methods and potential side effects as defined by the method information index
6. Estimate the percentage of FP clients who would recommend the WISH services as evidenced by the net promoter score (NPS)
7. Estimate the percentage of WISH clients who demonstrated positive attitudes, practices and community support in relation to FP and SRHR
8. Estimate the percentage of FP clients at WISH service delivery points reporting exposure to WISH social and behavioral change communication (SBCC) activities
9. Estimate the percentage of users of FP services by WISH service delivery points who have a disability.
10. Understand why FP users changed methods
11. Explore the predictors of FP adopters
12. Explore the predictors of being likely to promote FP services
13. Determine effect of Social and Behavior Change Communication (SBCC) campaign on outcomes of interest
|
Uganda |
2020-06-01 |
2023-06-01 |
Medical and Health Sciences |
|
Non-degree Award |
|
Pontiano Kaleebu
ID: UNCST-2021-R013577
|
Uganda Virus Research Institute Performance Evaluation for COVID-19 Diagnostic tests
REFNo: HS637ES
Overall objectives
The overall objectives of this performance evaluation are:
- To verify the performance characteristics of new on-the-market NAATs,
- To evaluate the performance characteristics of new, on-the-market, EIAs and RDTS (IgA, IgG and IgM),
- To train laboratory and POC staff in the country in biosecurity and the required technical skills to perform COVID-19 diagnostic testing,
- To establish serum/plasma panels of well-characterized COVID-19 sera/plasma to support evaluation efforts.
Specific Objectives:
- To confirm whether or not a new NAAT complies with the manufacturer’s specifications,
- To determine the performance equivalence of new on-the-market NAATs using the Berlin protocol NAAT as the gold standard,
- To determine the sensitivity and specificity of new on-the-market diagnostic EIAs and RDTs against a gold-standard method,
- To evaluate the operational characteristics of new on-the-market immunoassays. Operational utility characteristics that may be considered include;
o ease of performance
o specimen type utility
o inter-reader variability
o reaction endpoint stability
o suitability for use in facilities with limited infrastructure (no/limited electricity, no/limited clean water, inadequate means of biosafety disposal)
- To document Standard Operating Procedures (SOPs) and train laboratory staff in the country in performing COVID-19 diagnostic testing using recommended EIAs and RDTs,
- To establish serum panels of well characterized COVID-19 sera/plasma to support future validation and evaluation of immunoassays.
|
Uganda |
2020-05-20 |
2023-05-20 |
Medical and Health Sciences |
|
Non-degree Award |
|
Badru Bukenya
ID:
|
Displaced communities, environmental degradation and sustainable livelihoods in Uganda

REFNo: SS310ES
(i) understand the various ways in which refugees and nationals living in or around new and long-term refugee settlements interact with the environment and ecosystem services.
(ii) explore the variety of knowledges (indigenous; cultural, social and economic) and needs (shelter, food, water, sanitation) of refugee and local households for understanding how the environment is used.
(iii) examine the nature and extent of environmental degradation (loss of forests/fragmentation and soil degradation) in different camp settlements. And,
(iv) offer recommendations for the management of increasing pressure on land resources within sustainable livelihood practices for development and policy programming.
|
Uganda |
2020-05-08 |
2023-05-08 |
Social Science and Humanities |
|
Non-degree Award |
|
Hussein Kafeero Mukasa
ID:
|
HEPATITIS B GENOTYPES AND IL-2, 4, 10, INF-γ, TNF-α, PROMOTER GENE POLYMORPHISMS IN A HIGH AND LOW ENDEMIC REGION OF UGANDA
REFNo: HS575ES
1. To determine the circulating hepatitis B virus genotypes in regions of high and low endemicity in Uganda.
2. To characterize Th1/Th2 cytokine gene promoter polymorphisms among HBV unexposed and exposed individuals in low and high endemicity regions.
3. To investigate the relationship between hepatitis B virus genotype and the observed Th1/Th2 cytokine gene promoter polymorphisms
4. To determine the expression levels of the cytokines and correlate them with the infecting genotypes and the single nucleotide polymorphisms in the Th1/Th2 cytokine gene promoter.
|
Uganda |
2020-04-30 |
2023-04-30 |
Medical and Health Sciences |
|
Degree Award |
|
ERIC WOBUDEYA
ID: UNCST-2019-R001047
|
A randomised trial of 6 months intensified anti-tuberculosis and 2 months anti-inflammatory treatment for HIV-infected and HIV-uninfected African and Asian children with tuberculous meningitis
REFNo: HS593ES
Main objectives of the SURE trial
a) To determine whether the standard 12 month ATT regimen for treating paediatric TBM can be reduced to 6 months with similar efficacy and safety, with an intensified regimen of anti-TB drugs in children aged under 15 years with TBM AND b) To determine whether adjunctive aspirin for the first 60 days of treatment reduces TBM-related neuro-disability with minimal or no toxicity in children with TBM.
Other objectives
(a) To determine whether the doses of anti-TB drugs, prescribed according to weight bands, result in appropriate drug exposures when compared with historical paediatric and adult PK data.
(b) To further understand the pathophysiology of TBM in children and the effects of intensified antibacterial and anti-inflammatory treatment on intra-cerebral inflammation and the macroscopic complications of TBM (infarcts, tuberculomas, hydrocephalus).
|
Uganda |
2020-04-30 |
2023-04-30 |
Medical and Health Sciences |
|
Non-degree Award |
|
Annette Schuh Hildegard
ID: UNCST-2024-R003745
|
Evaluation and Transfer of mobile whole slide tissue scanners and liquid biopsies to deliver fast and precise diagnosis for improved outcomes of children and young adults with EBV-driven lymphoma: a joint Tanzanian and Ugandan Paediatric Oncology Network Initiative
REFNo: HS529ES
We have four objectives: to
1. Assess the diagnostic accuracy of liquid biopsy testing
2. Asses the diagnostic accuracy of digital pathology
3. Development of a digital pathology machine learning algorithm
4. Transfer of above novel tests and associated expertise to local laboratories
|
UK |
2020-04-24 |
2023-04-24 |
Medical and Health Sciences |
|
Non-degree Award |
|
Peter Nkurunziza Munya
ID:
|
'Evaluation of The Bio-Rad Geenius HIV-1/2 Confirmatory Assay as Part of Confirmatory and Differentiation of HIV infection at Uganda Virus Research Institute-HIV Reference Laboratory'
REFNo: HS612ES
Primary objective
• To conduct an in-country evaluation of the performance of Geenius™ HIV-1/2 Confirmatory Assay for confirmation of HIV infection using DBS and Plasma specimens, as compared to Murex HIV Ag/Ab Combination and/or Genscreen Ultra HIV Ag/Ab Combo.
Specific objectives
• To determine the sensitivity of Geenius™ HIV-1/2 Confirmatory Assay as compared to Murex HIV Ag/Ab Combination and/or Genscreen Ultra HIV Ag/Ab Combo
• To determine the specificity of the Geenius™ HIV-1/2 Confirmatory Assay as compared to Murex HIV Ag/Ab Combination and/or Genscreen Ultra HIV Ag/Ab Combo
• To determine the positive predictive value and negative predictive value of Geenius™ HIV-1/2 Confirmatory Assay as compared to Murex HIV Ag/Ab Combination and/or Genscreen Ultra HIV Ag/Ab Combo.
|
Uganda |
2020-04-24 |
2023-04-24 |
Medical and Health Sciences |
|
Non-degree Award |
|
PROSPER BEHUMBIIZE
ID:
|
Implementation Research on Education Management Information Systems (EMIS) Data Use Innovations in Uganda
REFNo: SIR33ES
1. To assess the existing management information systems for the Education Sector
2. To understand how innovations including DHIS2 can be used to improve EMIS data quality, management and use at all levels of the education sector
3. To ascertain the best practices that will inform scale up of Dhis2-for Education within and across countries
|
Uganda |
2020-04-17 |
2023-04-17 |
Engineering and Technology |
|
Non-degree Award |
|
Peter Olupot-Olupot
ID:
|
Coronavirus Disease 2019 Open Cohort (COC) Study
REFNo: HS611ES
The specific objectives:
1. Through a cross sectional survey describe risk factors and enlist study participants for the cohort study.
2. To characterize the clinical spectrum of COVID-19.
3. To refine case definitions of COVID-19 using data from different population groups.
4. To explore in detail, the epidemiology of COVID-19.
5. To document outcomes associated with COVID-19 in various age groups, populations and concomitant conditions.
6. To generate data to inform clinical research on COVID-19.
7. To generate population specific data for evidence based public health education as a control measure.
8. Provide a decision tree that has automated feedback that has standard of care including quarantine, call help-line, seek medical attention and avoid spread of the disease.
|
Uganda |
2020-04-03 |
2023-04-03 |
Medical and Health Sciences |
|
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|